Dr Tony Flinn

Tony is a Venture Partner with Catapult’s GM&C Life Sciences Fund, where he helps assess service company (CRO) investment opportunities and works with the Fund’s smaller investments to help companies successfully grow.

Tony is a well-known non-executive director and motivational speaker who co-founded Onyx Scientific in 2000 to offer contract chemistry services to many of the world’s leading drug developers. He grew the business to become one the fastest growing technology companies in the UK, employing more than 60 staff at its peak, managed an MBO in 2007, and ultimately sold the business to IPCA, a large Indian pharmaceutical service provider, in 2011.

Tony began his career as a Post-Doctoral Research Fellow, first with the Cancer Research Institute, and then with Oxford University. After a period as a Research Chemist with Dow Chemical he began the first of several business development roles.   

Tony holds a First Class BSc in Chemistry and PhD in Synthetic Organic Chemistry, both from Heriot-Watt University. He is a Fellow of the Royal Society of Chemistry and a Chartered Chemist (FRSC CChem).